CIK 0000818686 · Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972 (3) 914-8213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- 4 Option exercise Chief Accounting Officer acquired 3,566 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise EVP, Chief Financial Officer acquired 21,390 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Option exercise See "Remarks" acquired 23,765 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Exec. VP, European Commercial sold 70,961 shares at an average $15.91 ($1,128,642)
- 4 Derivatives Options or other derivatives
- 4 Option exercise Chief Accounting Officer acquired 16,326 shares (option exercise)
- 4 Planned sale EVP, Head of U.S. Commercial sold 6,181 shares at an average $15.80 ($97,639)
- 4 Planned sale EVP, Chief Legal Officer sold 4,827 shares at an average $15.80 ($76,250)
- 4 Option exercise EVP, Chief Financial Officer acquired 239,932 shares (option exercise)
- 4 Planned sale See "Remarks" sold 23,251 shares at an average $15.80 ($367,288)
- 4 Option exercise See "Remarks" acquired 235,282 shares (option exercise)
- 4 Planned sale Exec. VP, European Commercial sold 140,372 shares at an average $15.80 ($2,217,407)
- 4 Planned sale President and CEO sold 23,773 shares at an average $15.80 ($375,534)
- 144 Insider Sale of Securities
- 4 Option exercise Chief Accounting Officer acquired 5,179 shares (option exercise)
Page 12 of 128 · 2,555 filings